241 related articles for article (PubMed ID: 3280598)
1. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.
Karpatkin S; Pearlstein E; Ambrogio C; Coller BS
J Clin Invest; 1988 Apr; 81(4):1012-9. PubMed ID: 3280598
[TBL] [Abstract][Full Text] [Related]
2. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
Nierodzik ML; Klepfish A; Karpatkin S
Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
[TBL] [Abstract][Full Text] [Related]
3. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo.
Nierodzik ML; Kajumo F; Karpatkin S
Cancer Res; 1992 Jun; 52(12):3267-72. PubMed ID: 1596884
[TBL] [Abstract][Full Text] [Related]
4. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.
Nierodzik ML; Plotkin A; Kajumo F; Karpatkin S
J Clin Invest; 1991 Jan; 87(1):229-36. PubMed ID: 1845869
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
6. Adhesive protein expression on thrombin-stimulated platelets: time-dependent modulation of anti-fibrinogen, -fibronectin, and -von Willebrand factor antibody binding.
Peerschke EI
Blood; 1992 Feb; 79(4):948-53. PubMed ID: 1737104
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet integrin GPIIb-GPIIIa, fibronectin, von Willebrand factor, and thrombin in platelet-tumor interaction in vitro and metastasis in vivo.
Nierodzik ML; Klepfish A; Karpatkin S
Semin Hematol; 1994 Oct; 31(4):278-88. PubMed ID: 7831573
[No Abstract] [Full Text] [Related]
9. Shear stress-induced binding of von Willebrand factor to platelets.
Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
[TBL] [Abstract][Full Text] [Related]
10. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
11. Multiple platelet surface receptors mediate platelet adhesion to surfaces coated with plasma proteins.
DiFazio LT; Stratoulias C; Greco RS; Haimovich B
J Surg Res; 1994 Jul; 57(1):133-7. PubMed ID: 8041127
[TBL] [Abstract][Full Text] [Related]
12. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
Reverter JC; Béguin S; Kessels H; Kumar R; Hemker HC; Coller BS
J Clin Invest; 1996 Aug; 98(3):863-74. PubMed ID: 8698879
[TBL] [Abstract][Full Text] [Related]
14. [Platelet structure and function: immunocytochemical localizations of membrane glycoprotein and alpha-granule protein].
Suzuki H; Yamazaki H; Tanoue K
Nihon Rinsho; 1992 Feb; 50(2):218-22. PubMed ID: 1319510
[TBL] [Abstract][Full Text] [Related]
15. Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets.
Plow EF; McEver RP; Coller BS; Woods VL; Marguerie GA; Ginsberg MH
Blood; 1985 Sep; 66(3):724-7. PubMed ID: 3875376
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein Ib has a partial role in platelet-von Willebrand factor collagen interaction.
Aihara M; Tamura K; Kawarada R; Okawa K; Yoshida Y
Thromb Haemost; 1988 Oct; 60(2):182-7. PubMed ID: 3064358
[TBL] [Abstract][Full Text] [Related]
17. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
[TBL] [Abstract][Full Text] [Related]
19. The role of the porcine von Willebrand factor: baboon platelet interactions in pulmonary xenotransplantation.
Gaca JG; Lesher A; Aksoy O; Ruggeri ZM; Parker W; Davis RD
Transplantation; 2002 Dec; 74(11):1596-603. PubMed ID: 12490794
[TBL] [Abstract][Full Text] [Related]
20. Targeting platelet GPIbβ reduces platelet adhesion, GPIb signaling and thrombin generation and prevents arterial thrombosis.
Maurer E; Tang C; Schaff M; Bourdon C; Receveur N; Ravanat C; Eckly A; Hechler B; Gachet C; Lanza F; Mangin PH
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1221-9. PubMed ID: 23559635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
